PD, PK, and Safety of ALTO-203 in Patients With MDD
Trial details
- Registry ID
- NCT06391593
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| PD, PK, and Safety of ALTO-203 in Patients With MDDNCT06391593 | Alto Neuroscience | Phase 2 | Completed | 2025-04-14Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |